| Literature DB >> 20053301 |
Gerald L Weinhouse1, Richard J Schwab, Paula L Watson, Namrata Patil, Bernardino Vaccaro, Pratik Pandharipande, E Wesley Ely.
Abstract
Delirium occurs frequently in critically ill patients and has been associated with both short-term and long-term consequences. Efforts to decrease delirium prevalence have been directed at identifying and modifying its risk factors. One potentially modifiable risk factor is sleep deprivation. Critically ill patients are known to experience poor sleep quality with severe sleep fragmentation and disruption of sleep architecture. Poor sleep while in the intensive care unit is one of the most common complaints of patients who survive critical illness. The relationship between delirium and sleep deprivation remains controversial. However, studies have demonstrated many similarities between the clinical and physiologic profiles of patients with delirium and sleep deprivation. This article aims to review the literature, the clinical and neurobiologic consequences of sleep deprivation, and the potential relationship between sleep deprivation and delirium in intensive care unit patients. Sleep deprivation may prove to be a modifiable risk factor for the development of delirium with important implications for the acute and long-term outcome of critically ill patients.Entities:
Mesh:
Year: 2009 PMID: 20053301 PMCID: PMC2811939 DOI: 10.1186/cc8131
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Clinical and physiologic similarities shared by delirium and sleep disruption
| Clinical features |
| Inattention |
| Fluctuating mental status |
| Impaired cognition, specifically those relating to executive function (memory, planning, creative thinking, judgment) |
| Delayed recovery after the insult is removed |
| Risk factors |
| Intensive care unit admission |
| Mechanical ventilation |
| Pain |
| Stress |
| Pre-existing cognitive impairment |
| Advanced age |
| Alcoholism |
| Depression |
| Sepsis |
| Head trauma |
| Medications |
| Sedatives, especially γ-aminobutyric acid agonists such as benzodiazepines |
| Anticholinergics |
| Sympathomimetics |
| Corticosteroids |
| Anticonvulsants |
| Pathophysiology |
| Cholinergic deficiency |
| Dopaminergic excess |
| Altered metabolism at specific regions of the central nervous system |
| Prefrontal cortex |
| Posterior parietal cortex |
Medications that can cause delirium and their effects on sleep
| Medication | Effect |
|---|---|
| Analgesics | |
| Opioids | Decreased REM, decreased SWS |
| Nonsteroidal anti-inflammatory agents | Decreased total sleep time, decreased sleep efficiency |
| Anesthetics | |
| Isoflurane | Decreased SWS |
| Anticholinergics | |
| Diphenhydramine | Decreased sleep latency, decreased REM |
| Benztropine | Decreased REM |
| Anticonvulsants | |
| Phenytoin | Sleep fragmentation, increased SWS |
| Carbamazepine | Decreased REM, increased SWS |
| Valproic acid | Decreased nocturnal melatonin blood levels |
| Anti-Parkinson's agents | |
| Levodopa | At high doses, hallucinations, nightmares |
| Amantadine | Confusion, hallucinations |
| Cardiac drugs | |
| β-Blockers | Decreased total sleep time, REM, SWS (lipophilic > nonlipophilic) |
| Clonidine | Decreased REM |
| Digitalis | Insomnia, nightmares |
| Methyldopa | Decreased SWS, increased REM, nightmares |
| Corticosteroids | Decreased REM, decreased SWS |
| Psychiatric drugs | |
| Tricyclic antidepressants | Decreased REM |
| Selective serotonin reuptake inhibitors | Decreased REM, decreased total sleep time |
| Sedative/hypnotics | |
| Benzodiazepines | Decreased REM, decreased SWS |
REM, rapid eye movement; SWS, slow-wave sleep (stage III/IV).
Figure 1Delirium and some associated risk factors. A possible relationship between delirium and some of its associated risk factors, including sleep deprivation. ICU, intensive care unit.